AMI Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55M Sell
59,804
-1,743
-3% -$1.77M 3.51% 9
2025
Q4
$66.1M Sell
61,547
-1,385
-2% -$1.32M 3.75% 9
2025
Q3
$48M Sell
62,932
-1,020
-2% -$759K 2.68% 14
2025
Q2
$49.9M Sell
63,952
-3,615
-5% -$2.81M 2.85% 11
2025
Q1
$55.8M Sell
67,567
-2,084
-3% -$1.73M 3.27% 10
2024
Q4
$53.8M Sell
69,651
-1,542
-2% -$1.28M 2.86% 14
2024
Q3
$63.1M Sell
71,193
-1,999
-3% -$1.8M 3.42% 9
2024
Q2
$66.3M Sell
73,192
-300
-0.4% -$240K 3.57% 5
2024
Q1
$57.2M Sell
73,492
-28,610
-28% -$20.4M 2.92% 13
2023
Q4
$59.5M Sell
102,102
-189
-0.2% -$110K 3.25% 10
2023
Q3
$54.9M Sell
102,291
-2,035
-2% -$1.05M 3.4% 9
2023
Q2
$48.9M Sell
104,326
-19,442
-16% -$8.15M 2.91% 17
2023
Q1
$42.5M Buy
+123,768
New +$41.7M 2.71% 19

Other funds holding LLY

AMI Asset Management's LLY Position: Q1 2026 in Review

AMI Asset Management reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $1.77M and leaving 59,804 shares worth $55M. The position accounts for 3.51% of the portfolio, ranked #9.

AMI Asset Management first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $66.3M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • AMI Asset Management held 59,804 shares of Eli Lilly worth $55M as of Q1 2026.
  • AMI Asset Management sold 1,743 Eli Lilly shares in Q1 2026, an estimated $1.77M.
  • Eli Lilly made up 3.51% of AMI Asset Management's portfolio in Q1 2026, its #9 holding.
  • AMI Asset Management first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • AMI Asset Management's Eli Lilly position peaked at $66.3M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on AMI Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.